BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 11456220)

  • 1. Neutral magnesium-dependent sphingomyelinase from liver plasma membrane: purification and inhibition by ubiquinol.
    Martín SF; Navarro F; Forthoffer N; Navas P; Villalba JM
    J Bioenerg Biomembr; 2001 Apr; 33(2):143-53. PubMed ID: 11456220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquinol inhibition of neutral sphingomyelinase in liver plasma membrane: specific inhibition of the Mg(2+)-dependent enzyme and role of isoprenoid chain.
    Martín SF; Gómez-Díaz C; Navas P; Villalba JM
    Biochem Biophys Res Commun; 2002 Sep; 297(3):581-6. PubMed ID: 12270134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of neutral Mg2+-dependent sphingomyelinase by ubiquinol-mediated plasma membrane electron transport.
    Martín SF; Gómez-Díaz C; Bello RI; Navas P; Villalba JM
    Protoplasma; 2003 May; 221(1-2):109-16. PubMed ID: 12768348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and characterization of a magnesium-dependent neutral sphingomyelinase from bovine brain.
    Bernardo K; Krut O; Wiegmann K; Kreder D; Micheli M; Schäfer R; Sickman A; Schmidt WE; Schröder JM; Meyer HE; Sandhoff K; Krönke M
    J Biol Chem; 2000 Mar; 275(11):7641-7. PubMed ID: 10713073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and characterization of a membrane bound neutral pH optimum magnesium-dependent and phosphatidylserine-stimulated sphingomyelinase from rat brain.
    Liu B; Hassler DF; Smith GK; Weaver K; Hannun YA
    J Biol Chem; 1998 Dec; 273(51):34472-9. PubMed ID: 9852115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The subcellular localization of neutral sphingomyelinase in rat liver.
    Hostetler KY; Yazaki PJ
    J Lipid Res; 1979 May; 20(4):456-63. PubMed ID: 37279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of three competitive inhibitors for membrane-associated, Mg2+-dependent and neutral 60 kDa sphingomyelinase activity.
    Kim SK; Jung SM; Ahn KH; Jeon HJ; Lee DH; Jung KM; Jung SY; Kim DK
    Arch Pharm Res; 2005 Aug; 28(8):923-9. PubMed ID: 16178418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceramide-dependent caspase 3 activation is prevented by coenzyme Q from plasma membrane in serum-deprived cells.
    Navas P; Fernandez-Ayala DM; Martin SF; Lopez-Lluch G; De Caboa R; Rodriguez-Aguilera JC; Villalba JM
    Free Radic Res; 2002 Apr; 36(4):369-74. PubMed ID: 12069099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphatidylinositol-3,5-Bisphosphate is a potent and selective inhibitor of acid sphingomyelinase.
    Kölzer M; Arenz C; Ferlinz K; Werth N; Schulze H; Klingenstein R; Sandhoff K
    Biol Chem; 2003 Sep; 384(9):1293-8. PubMed ID: 14515991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the neutral magnesium-dependent sphingomyelinase by glutathione.
    Liu B; Hannun YA
    J Biol Chem; 1997 Jun; 272(26):16281-7. PubMed ID: 9195931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NAD+/NADH and/or CoQ/CoQH2 ratios from plasma membrane electron transport may determine ceramide and sphingosine-1-phosphate levels accompanying G1 arrest and apoptosis.
    De Luca T; Morré DM; Zhao H; Morré DJ
    Biofactors; 2005; 25(1-4):43-60. PubMed ID: 16873929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A neutral magnesium-dependent sphingomyelinase isoform associated with intracellular membranes and reversibly inhibited by reactive oxygen species.
    Fensome AC; Rodrigues-Lima F; Josephs M; Paterson HF; Katan M
    J Biol Chem; 2000 Jan; 275(2):1128-36. PubMed ID: 10625655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and evaluation of neutral sphingomyelinase 2 inhibitors.
    Lee DH; Kim SH; Ahn KH; Kim SK; Choi JM; Ji JE; Won JH; Park YH; Lim C; Kim S; Kim DK
    Arch Pharm Res; 2011 Feb; 34(2):229-36. PubMed ID: 21380806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of magnesium-dependent, neutral sphingomyelinase by phosphatidylserine.
    Tamiya-Koizumi K; Kojima K
    J Biochem; 1986 Jun; 99(6):1803-6. PubMed ID: 3017927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics and partial purification of a novel cytosolic, magnesium-independent, neutral sphingomyelinase activated in the early signal transduction of 1 alpha,25-dihydroxyvitamin D3-induced HL-60 cell differentiation.
    Okazaki T; Bielawska A; Domae N; Bell RM; Hannun YA
    J Biol Chem; 1994 Feb; 269(6):4070-7. PubMed ID: 8307965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of neutral sphingomyelinase on phenylephrine-induced vasoconstriction and Ca(2+) mobilization in rat aortic smooth muscle.
    Zheng T; Li W; Wang J; Altura BT; Altura BM
    Eur J Pharmacol; 2000 Mar; 391(1-2):127-35. PubMed ID: 10720644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the neutral pH-optimum sphingomyelinase from rat brain: inhibition by copper II and ganglioside GM3.
    Lister MD; Crawford-Redick CL; Loomis CR
    Biochim Biophys Acta; 1993 Jan; 1165(3):314-20. PubMed ID: 8418889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification, partial purification, and localization of a neutral sphingomyelinase in rabbit skeletal muscle: neutral sphingomyelinase in skeletal muscle.
    Ghosh N; Sabbadini R; Chatterjee S
    Mol Cell Biochem; 1998 Dec; 189(1-2):161-8. PubMed ID: 9879667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Existence of Mg2+-dependent, neutral sphingomyelinase in nuclei of rat ascites hepatoma cells.
    Tamiya-Koizumi K; Umekawa H; Yoshida S; Kojima K
    J Biochem; 1989 Oct; 106(4):593-8. PubMed ID: 2558112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutral sphingomyelinase from human urine. Purification and preparation of monospecific antibodies.
    Chatterjee S; Ghosh N
    J Biol Chem; 1989 Jul; 264(21):12554-61. PubMed ID: 2545711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.